Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) just unveiled an update.
NeuroScientific Biopharmaceuticals Limited announced the cessation of Anthony Keating as a director, effective June 26, 2025. This change in the board may influence the company’s strategic direction and stakeholder interests, particularly in its ongoing efforts to advance treatments for neurodegenerative diseases.
More about Neuroscientific Biopharmaceuticals Ltd.
NeuroScientific Biopharmaceuticals Limited operates in the biopharmaceutical industry, focusing on the development of therapeutic products targeting neurodegenerative conditions.
Average Trading Volume: 428,090
Technical Sentiment Signal: Buy
Current Market Cap: A$13.01M
For detailed information about NSB stock, go to TipRanks’ Stock Analysis page.